Home > Healthcare > Medical Devices > Therapeutic Devices > Proton Therapy Systems Market

Proton Therapy Systems Market Share

Report ID: GMI6685
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Proton Therapy Systems Market Share

Some of the eminent market participants operating in the proton therapy systems market include

IBA worldwide
Hitachi
Mevion Medical Systems
Optivus Proton Therapy
Advanced Oncotherapy plc
Mitsubishi Electric Corporation
Varian
Ion Beam Applications SA
ProTom International
Provision Healthcar
Sumitomo Heavy Industries, Ltd.

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Proton therapy systems industry size was USD 1.2 billion in 2022 and will reach USD 3.2 billion by 2032 due to the increasing prevalence of cancer cases worldwide.

Proton therapy systems industry from the gastro-intestinal cancer application segment reached USD 322 million in 2022 on account of its prevalence as the third most diagnosed cancer globally.

U.S. proton therapy systems industry size registered USD 530 million in 2022 and is expected to witness appreciable growth from 2023-2032 owing to clinical advantages, broader recognition, and investments in infrastructure and research in the region.

IBA worldwide, Hitachi, Mevion Medical Systems, Optivus Proton Therapy, Advanced Oncotherapy plc, Mitsubishi Electric Corporation, Varian, Ion Beam Applications SA, ProTom International, and Provision Healthcare are some of the major proton therapy system companies worldwide.